Prevalence of spinocerebellar ataxia 36 in a US population

Juliana M. Valera, Tatyana Diaz, Lauren E. Petty, Beatriz Quintáns, Zuleima Yáñez, Eric Boerwinkle, Donna Muzny, Dmitry Akhmedov, Rebecca Berdeaux, Maria J. Sobrido, Richard Gibbs, James R. Lupski, Daniel H. Geschwind, Susan Perlman, Jennifer E. Below, Brent L. Fogel

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Objective: To assess the prevalence and clinical features of individuals affected by spinocerebellar ataxia 36 (SCA36) at a large tertiary referral center in the United States. Methods: A total of 577 patients with undiagnosed sporadic or familial cerebellar ataxia comprehensively evaluated at a tertiary referral ataxia center were molecularly evaluated for SCA36. Repeat primed PCR and fragment analysis were used to screen for the presence of a repeat expansion in the NOP56 gene. Results: Fragment analysis of triplet repeat primed PCR products identified a GGCCTG hexanucleotide repeat expansion in intron 1 of NOP56 in 4 index cases. These 4 SCA36-positive families comprised 2 distinct ethnic groups: white (European) (2) and Asian (Japanese [1] and Vietnamese [1]). Individuals affected by SCA36 exhibited typical clinical features with gait ataxia and age at onset ranging between 35 and 50 years. Patients also suffered from ataxic or spastic limbs, altered reflexes, abnormal ocular movement, and cognitive impairment. Conclusions: In a US population, SCA36 was observed to be a rare disorder, accounting for 0.7% (4/577 index cases) of disease in a large undiagnosed ataxia cohort.

Original languageEnglish
JournalNeurology: Genetics
Volume3
Issue number4
DOIs
StatePublished - 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prevalence of spinocerebellar ataxia 36 in a US population'. Together they form a unique fingerprint.

Cite this